Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Explore effective ways to monetize your blog or website. Learn proven strategies to boost your online income and achieve success.
8,001 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Berkshire Hathaway has quietly built a near-10% stake in Domino’s Pizza, signaling a long-term, cash-flow driven thes...
Rivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
A new ActivTrak analysis finds AI isn’t reducing workloads employees, instead boosting routine tasks and trimming dee...
Crypto swings may lift Coinbase, but the real upside comes from non crypto revenue streams. This guide explains why t...
A colossal AI infrastructure agreement links Meta Platforms with Nebius in a five-year plan worth $27 billion. This a...
Opendoor Technologies shares jumped about 6% as the company posted a strong Q4 and policy tailwinds boosted the stock...
Markets are rotating away from AI hype toward real, tangible assets. A small engineering firm is asserting itself wit...
Palantir's journey has been a roller coaster—massive gains, sharp pulls, and ongoing questions. This guide distills w...
Salesforce delivered a solid Q4 beat and announced a $50 billion buyback, but FY27 guidance disappointed investors. T...
Rivian and NIO shares fell about 7% amid renewed skepticism about rapid EV growth. Investors are demanding clear prof...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...